Gwendolyn Binder

President, Science & Technology Cabaletta Bio

Seminars

Tuesday 24th February 2026
C-Level Think Tank
2:45 pm

A closed door discussion uniting top C-level executives from biotech and senior executives from pharma to discuss the most pressing challenges and advancements shaping the CAR-TCR field in Europe. This year’s Think Tank explores Tregs in autoimmune disease to understand how they can be leveraged as therapies and their significance when other effector cell therapies are used.

Invite Only

Co Chairs:

Gwendolyn Binder